Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Key Players companies in Dengue vaccine
by Highest Patent Value in the world in 2021

The Dengue vaccine top 10 is Discovery PatSnap’ annual ranking of the top 10 Highest Patent Value Dengue vaccine Key Players in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Dengue vaccine is a vaccine to prevent dengue fever in humans. The World Health Organization (WHO) only recommends the vaccine in those who have previously had dengue fever or populations in which most people have been previously infected. The value of this vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected.
#
Company Name
Region
Tech Topics
Total
1
Clinical trial,Pharmacy and Therapeutics,Glycobiology,
...[+2]
Avg patent value: 5.18 M
2
Kumamoto, Japan
Blood plasma,Medicine,Suture (anatomy),
...[+2]
Avg patent value: 1.56 M
3
Belgium
Avg patent value: 1.31 M
4
Health care,Biopharmaceutical,Drug,
...[+2]
Avg patent value: 1.18 M
5
Avg patent value: 1.18 M
6
Medicine,Pharmacy and Therapeutics,Gene delivery,
...[+2]
Avg patent value: 340,000
7
Delhi, India
Medicine,Health care,Biotechnology,
...[+2]
Avg patent value: 310,000
8
Sichuan Sheng, China
Avg patent value: 79,500
9
MT, US
Avg patent value: 69,740
10
Rhône-Alpes, France
Health care,Poliomyelitis,Typhoid fever,
...[+2]
Avg patent value: 66,000
Page generation time: Jul 11 2025